Serum Aβ Levels as Predictors of Conversion to Mild Cognitive Impairment/Alzheimer Disease in an ADAPT Subcohort Mar 23, 2026
Cross validation of the Montreal Cognitive Assessment in community dwelling older adults residing in the Southeastern US Mar 23, 2026
Cognitive function over time in the Alzheimer’s Disease Anti-inflammatory Prevention Trial (ADAPT): Mar 19, 2026Results of a Randomized, Controlled Trial of Naproxen and Celecoxib
The influence of diagnosis, intra- and inter-person variability on serum and plasma Aβ levels Mar 19, 2026
